부작용 코로나 백신 경미한 부작용 보고... 존슨앤존슨은 임상실험 포기자 나와<br /><br />Around a week ago, AstraZeneca's COVID-19 vaccine was put on temporary hold due to signs of serious side effects.<br />While the trial is back on, Pfizer's vaccine also reported mild side effects.<br />Other companies manufacturing vaccines have also been affected by the news.<br />Our Kim Do-yeon starts us off.<br />It's been a week since AstraZeneca reported adverse reactions during COVID-19 vaccine trial... and Pfizer also reported mild-to-moderate side effects from the vaccine it is trialing.<br />According to Pfizer's executives, over twelve-thousand participants have received a second dose.<br />Over 29,000 volunteers have already been chosen, and the goal is to have 44,000.<br />While the company is closely analyzing the safety and tolerability of the vaccine during the study, an independent data monitoring committee could recommend a pause at any time.<br />While AstraZeneca's resumed its trials on Monday, the news still affected people worldwide.<br />Some of Johnson and Johnson's volunteers, worried about the side effects, have quit.<br />However, the company claimed the situation is under control.<br />"Still, it hasn't affected us much, because the number of volunteers, particularly in the 18 to 55 age-group, have left us with enough reserve volunteers."<br />The firm's Belgian unit began its Phase II of trials in Spain this week.<br />The company aims to test 60-thousand people globally in Phase Three and include people from all walks of life.<br />In the meantime, China could have a vaccine ready for the public as early as November according to an official with the Chinese Center for Disease Control and Prevention.<br />She said the current Phase 3 of the clinical trials were proceeding smoothly and three of the country's vaccines have already been offered to essential workers under an emergency use program launched in July.<br />Kim Do-yeon, Arirang News<br />
